© 2002 by European Society of Cardiology
DEFIBRILLATORS
Malfunction of endocardial defibrillator leads and lead extraction: where do they meet?
Department of Cardiology, Catharina Hospital, Eindhoven The Netherlands
Manuscript submitted 30 January 2001. Accepted after revision 17 October 2001.
Correspondence: F. A. L. E. Bracke, P.O. Box 1350, 5602 ZA Eindhoven, The Netherlands. E-mail: f.bracke{at}skynet.be
Key Words: Implantable defibrillators, leads, lead extraction, complications of lead extraction
Aims
The development of new extraction techniques has improved the success rate of intravascular extraction of pacemaker and defibrillator leads, and hence the practice of extraction is expanding. However, the indications for lead extraction of malfunctioning leads in patients with an implantable cardioverter defibrillator (ICD) are still not well established.
Methods and Results
We reviewed the literature concerning structural complications of ICD leads. The clinical presentation and detection of malfunction is discussed as well as the consequences for adequate defibrillation therapy. An overview of the current published experience of intravascular extraction of ICD leads is provided including a brief discussion of our own experience.
Conclusion
From this overview we conclude that malfunctioning pace-sense or ICD leads can be left in situ if there are no uncovered insulation defects. Inserting a new pace-sense or ICD lead is preferable in this situation given the current known complication rate of lead extraction. Lead extraction should be reserved for damaged leads in which interference with proper detection or defibrillation of newly inserted leads cannot be excluded.
References
[1] Love CJ, Wilkoff BL, Byrd CL, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000; 23: 544–551.[CrossRef][Medline]
[2] Stambler BS, Wood MA, Damiano RJ, Greenway PS, Smutka ML, Ellenbogen KA. Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: worldwide experience from the Guardian ATP 4210 clinical trial. J Am Coll Cardiol 1994; 23: 123–132.[Abstract]
[3] Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Gottlieb CD, Marchlinski FE. Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol 1995; 26: 776–786.[Abstract]
[4] Fahy GJ, Kleman JM, Wilkoff BL, Morant VA, Pinski SL. Low incidence of lead related complications associated with non-thoracotomy implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995; 18: 172–178.[CrossRef][Medline]
[5] Jones GK, Bardy GH, Kudenchuk PJ, et al. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future system design. Am Heart J 1995; 130: 327–333.[CrossRef][Web of Science][Medline]
[6] Lawton JS, Ellenbogen KA, Wood MA, et al. Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators. Am J Cardiol 1996; 78: 647–651.[CrossRef][Web of Science][Medline]
[7] Gupta A, Zegel HG, Dravid VS, Nierenberg SJ, Freiman DB. Value of radiography in diagnosing complications of cardioverter defibrillators implanted without thoracotomy in 437 patients. Am J Roentgenol 1997; 168: 105–108.
[8] Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. J Am Coll Cardiol 1996; 28: 400–410.[Abstract]
[9] Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral implantation of cardioverter defibrillators. World-Wide Jewel Investigators. Pacing Clin Electrophysiol 1997; 20: 208–211.[CrossRef][Medline]
[10] Tyers GF, Sanders R, Jacqmein W. Reliability of coated wire defibrillation leads. Pacing Clin Electrophysiol 1999; 22: 174–178.[CrossRef][Medline]
[11] Gallik DM, Ben Zur UM, Gross JN, Furman S. Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol 1996; 19: 1089–1094.[CrossRef][Medline]
[12] Drucker EA, Brooks R, Garan H, et al. Malfunction of implantable cardioverter defibrillators placed by a non-thoracotomy approach: frequency of malfunction and value of chest radiography in determining cause. Am J Roentgenol 1995; 165: 275–279.
[13] Degeratu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000; 11: 21–24.[Web of Science][Medline]
[14] Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne JW, Ruskin JN. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995; 18: 973–979.[CrossRef][Medline]
[15] Renzulli A, Vitale N, D'Onofrio A, Cotrufo M. Implantable cardioverter defibrillator malfunction due to transvenous lead insulation break. Pacing Clin Electrophysiol 1994; 17: 245–246.[CrossRef][Medline]
[16] Schwartzman D, Hull ML, Callans DJ, Gottlieb CD, Marchlinski FE. Serial defibrillation lead impedance in patients with epicardial and non-thoracotomy lead systems. J Cardiovasc Electrophysiol 1996; 7: 697–703.[Web of Science][Medline]
[17] Epstein AE and Shepard RB. Failure of one conductor in a non-thoracotomy implantable defibrillator lead causing inappropriate sensing and potentially ineffective shock delivery. Pacing Clin Electrophysiol 1993; 16: 796–800.[CrossRef][Medline]
[18] Haddad L, Padula LE, Moreau M, Schoenfeld MH. Troubleshooting implantable cardioverter defibrillator system malfunctions: the role of impedance measurements. Pacing Clin Electrophysiol 1994; 17: 1456–1461.[CrossRef][Medline]
[19] Mehdirad AA, Stohr EC, Love CJ, Nelson SD, Schaal SF. Implantable defibrillators impedance measurement using pacing pulses versus shock delivery with intact and modified high voltage lead system. Pacing Clin Electrophysiol 1999; 22: 437–441.[CrossRef][Medline]
[20] Stevens J, Buchwald AB, Krieglstein H, Unterberg C. Early detection of lead fracture by painless high voltage lead impedance measurement in a transvenous ICD lead system. J Interv Card Electrophysiol 2000; 4: 269–272.[CrossRef][Web of Science][Medline]
[21] Gummert J, Krauss B, Hutschenreiter W, Hambrecht R, Mohr FW. Sensing lead insulation defect resulting in a damage of the ICD pulse generator case. Pacing Clin Electrophysiol 1998; 21: 478–479.[CrossRef][Medline]
[22] Lawton JS, Wood MA, Gilligan DM, Stambler BS, Damiano RJ Jr, Ellenbogen KA. Implantable transvenous cardioverter defibrillator leads: the dark side. Pacing Clin Electrophysiol 1996; 19: 1273–1278.[CrossRef][Medline]
[23] Mehta D, Nayak HM, Singson M, et al. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown. Pacing Clin Electrophysiol 1998; 21: 1893–1900.[CrossRef][Medline]
[24] Daoud EG, Man KC, Morady F, Strickberger SA. Rise in chronic defibrillation energy requirements necessitating implantable defibrillator lead system revision. Pacing Clin Electrophysiol 1997; 20: 714–719.[CrossRef][Medline]
[25] Pfitzner P and Trappe HJ. Oversensing in a cardioverter defibrillator system caused by interaction between two endocardial defibrillation leads in the right ventricle. Pacing Clin Electrophysiol 1998; 21: 764–768.[CrossRef][Medline]
[26] Nunain SO, Roelke M, Trouton T, et al. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 1995; 91: 2204–2213.
[27] Tang AS, Hendry P, Goldstein W, Green MS, Luce M. Non-thoracotomy implantation of cardioverter defibrillators: preliminary experience with a defibrillation lead placed at the right ventricular outflow tract. Pacing Clin Electrophysiol 1996; 19: 960–964.[CrossRef][Medline]
[28] Winter J, Heil JE, Schumann C, et al. Effect of implantable cardioverter/defibrillator lead placement in the right ventricle on defibrillation energy requirements. A combined experimental and clinical study. Eur J Cardiothorac Surg 1998; 14: 419–425.
[29] Fotuhi PC, KenKnight BH, Melnick SB, Smith WM, Baumann GF, Ideker RE. Effect of a passive endocardial electrode on defibrillation efficacy of a non-thoracotomy lead system. J Am Coll Cardiol 1997; 29: 825–830.[Abstract]
[30] Pacifico A, Wheelan KR, Nasir N Jr. Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. Circulation 1997; 95: 946–950.
[31] Minen G, Proclemer A, Facchin D. Asymptomatic superior vena caval occlusion: a complication of non-thoracotomy implantation of cardioverter defibrillator. Pacing Clin Electrophysiol 1998; 21: 1676–1678.[CrossRef][Medline]
[32] Dhondt E, Hutse W, Vanmeerhaeghe X, Jordaens L. Superior vena cava syndrome after implantation of a transvenous cardioverter defibrillator. Eur Heart J 1995; 16: 716–718.
[33] Le Franc P, Klug D, Jarwe M, et al. Extraction and reimplantation of defibrillation leads through a thrombotic subclavian vein. Pacing Clin Electrophysiol 1999; 22: 977–978.[CrossRef][Medline]
[34] Bracke FA, van Gelder LM, Sreeram N, Meijer A. Exchange of pacing or defibrillator leads following laser sheath extraction of non-functional leads in patients with ipsilateral obstructed venous access. Heart 2000; 83: E12.[CrossRef][Medline]
[35] Jensen SM, Pietersen A, Chen X. Implantation of active can implantable defibrillators in the right pectoral region. Pacing Clin Electrophysiol 1998; 21: 476–477.[CrossRef][Medline]
[36] Natale A, Sra J, Geiger MJ, Newby K, Akhtar M, Pacifico A. Right side implant of the unipolar single lead defibrillation system. Pacing Clin Electrophysiol 1997; 20: 1910–1912.[CrossRef][Medline]
[37] Schofield IJ, Rankin I, Bennett DH. Right sided pectoral implantation of an ‘active can’ transvenous implantable cardioverter-defibrillator with single right ventricular lead. Br Heart J 1995; 74: 204.
[38] Epstein AE, Kay GN, Plumb VJ, Voshage-Stahl L, Hull ML. Elevated defibrillation threshold when right-sided venous access is used for non-thoracotomy implantable defibrillator lead implantation. The Endotak Investigators. J Cardiovasc Electrophysiol 1995; 6: 979–986.[Web of Science][Medline]
[39] Friedman PA, Rasmussen MJ, Grice S, Trusty J, Glikson M, Stanton MS. Defibrillation thresholds are increased by right-sided implantation of totally transvenous implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1999; 22: 1186–1192.[CrossRef][Medline]
[40] Roberts PR, Allen S, Betts T, et al. Increased defibrillation threshold with right-sided active pectoral can. J Interv Card Electrophysiol 2000; 4: 245–249.[CrossRef][Web of Science][Medline]
[41] Jordaens L, Van Belleghem Y, Herregods L. Removal of endocardial defibrillation leads. Pacing Clin Electrophysiol 1996; 19: 127–129.[CrossRef][Medline]
[42] Le Franc P, Klug D, Jarwe M, et al. Extraction of endocardial implantable cardioverter-defibrillator leads. Am J Cardiol 1999; 84: 187–191.[CrossRef][Web of Science][Medline]
[43] Krishnan SC and Epstein LM. Initial experience with a laser sheath to extract chronic transvenous implantable cardioverter-defibrillator leads. Am J Cardiol 1998; 82: 1293–1295.[CrossRef][Web of Science][Medline]
[44] Vassilikos VP, Maounis TN, Chiladakis J, Cokkinos DV, Manolis AS. Percutaneous extraction of transvenous defibrillator leads using the VascoExtor pacing lead removal system. J Interv Card Electrophysiol 1999; 3: 247–251.[CrossRef][Web of Science][Medline]
[45] Kennergren C. Excimer laser assisted extraction of permanent pacemaker and ICD leads: present experiences of a European multi-centre study. Eur J Cardiothorac Surg 1999; 15: 856–860.
[46] Wilkoff BL, Byrd CL, Love CJ, et al. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol 1999; 33: 1671–1676.
[47] Smith HJ, Fearnot NE, Byrd CL, Wilkoff BL, Love CJ, Sellers TD. Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol 1994; 17: 2016–2020.[CrossRef][Medline]
[48] Byrd CL, Wilkoff BL, Love CJ, et al. Intravascular extraction of problematic or infected permanent pacemaker leads: 1994–1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol 1999; 22: 1348–1357.[CrossRef][Medline]
[49] Epstein AE, Kay GN, Plumb VJ, Dailey SM, Anderson PG. Gross and microscopic pathological changes associated with non-thoracotomy implantable defibrillator leads. Circulation 1998; 98: 1517–1524.
[50] Reiser C, Byrd CL, Wilkoff BL, Love CJ, Hayes DL, Sellers TD, Schaerf R. Pacing lead extraction with the Excimer sheath trial: final report. Pacing Clin Electrophysiol 1998; 22: 708.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Boriani, M. Biffi, A. Marziali, I. Diemberger, and C. Martignani A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance Europace, January 1, 2009; 11(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
A. Goette, F. Cantu, L. van Erven, P. Geelen, F. Halimi, J. L. Merino, J. M. Morgan, and on behalf of the Scientific Initiative Committee o Performance and survival of transvenous defibrillation leads: need for a European data registry Europace, January 1, 2009; 11(1): 31 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Ellenbogen, M. A. Wood, R. K. Shepard, H. F. Clemo, T. Vaughn, K. Holloman, M. Dow, J. Leffler, A. Abeyratne, and D. Verness Detection and management of animplantable cardioverter defibrillator lead failure: Incidence and clinical implications J. Am. Coll. Cardiol., January 1, 2003; 41(1): 73 - 80. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||